REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/22/2025
Back to search
Official data from USPTO
CONTRAFECT MOLECULAR TREATMENTS FOR INFECTIOUS DISEASE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
03/22/2025
Trademark type
Combined
Nice classes
42
Filing date
02/11/2015
Registration date
03/22/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/06/2022
Last transaction
03/22/2025
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Principal Register
First use anywhere
06/30/2011
First use in commerce
06/30/2011
Drawing code
3
Owner type
03
Owner location
Yonkers, NY
Examiner
MICKLEBURGH, LINDA
Law office
L60
Current location
TMEG LAW OFFICE 106
Mark description
The mark consists of the wording "CONTRAFECT MOLECULAR TREATMENTS FOR INFECTIOUS DISEASE" in blue letters beside a ball made up of orange dots.
Holders and representatives
Holders
C. C. (pessoa física)
Representatives
Matthew J. Solow Hoffmann & Baron, LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
PRODUCT RESEARCHNEW PRODUCT DEVELOPMENT SERVICESALL IN THE FIELDS OF INFECTIOUS DISEASES AND DISORDERSINCLUDING DISEASES AND DISORDERS CAUSED BY PATHOGENS; RESEARCH AND DEVELOPMENT OF NEW PRODUCTS PERTAINING TO THE TREATMENT OF INFECTIOUS DISEASES AND DISORDERSTO PHARMACEUTICALS; DEVELOPMENT OF NEW TECHNOLOGY FOR OTHERS PERTAINING TO THE TREATMENT OF INFECTIOUS DISEASES AND DISORDERSTO PHARMACEUTICALS; PROVIDING SCIENTIFIC INFORMATION FOR MEDICAL RESEARCH PURPOSESIN THE FIELDS OF INFECTIOUS DISEASES AND DISORDERSTREATMENTS FOR INFECTIOUS DISEASES AND DISORDERSPHARMACEUTICALS
Publications
History of USPTO decisions and trademark events.
21 publications found
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
09/06/2022
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
09/06/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/27/2022
ES8R
TEAS SECTION 8 RECEIVED
03/22/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/22/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
03/22/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/05/2016
PUBO
PUBLISHED FOR OPPOSITION
01/05/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/16/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/02/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/19/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/19/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/19/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/22/2015
GNRT
NON-FINAL ACTION E-MAILED
05/22/2015
CNRT
NON-FINAL ACTION WRITTEN
05/22/2015
DOCK
ASSIGNED TO EXAMINER
05/18/2015
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
02/27/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/26/2015
NWAP
NEW APPLICATION ENTERED
02/14/2015
Continuous trademark protection
Get notified about every new filing that threatens CONTRAFECT MOLECULAR TREATMENTS FOR INFECTIOUS DISEASE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.